Literature DB >> 9811931

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

M J Artiga1, M J Bullido, A Frank, I Sastre, M Recuero, M A García, C L Lendon, S W Han, J C Morris, J Vázquez, A Goate, F Valdivieso.   

Abstract

While the straightepsilon4 allele of apolipoprotein E ( APOE, gene; ApoE, protein) is widely accepted as a major genetic risk factor for the late onset form of Alzheimer's disease (AD), recent evidence points to variations in ApoE levels as another important factor. We have previously reported that a common variant in the regulatory region of APOE (-491A) is associated with risk for late onset AD. In this report we analyze the association of another APOE promoter polymorphism (-427T/C) with AD in two case-control clinical samples and demonstrate a correlation between APOE promoter transcriptional activity and risk for AD. The association studies show that the allelic variant (-427C) and the haplotype [-491A-427C] of the APOE promoter are associated with increased risk for AD. Study of the transcriptional activity of the common haplotypes defined by combination of the -491 and -427 alleles indicated that the risk for late onset AD positively correlates with transcriptional activity of the APOE gene, suggesting that increases in the local expression of ApoE could be responsible for the association of APOE promoter polymorphism with AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811931     DOI: 10.1093/hmg/7.12.1887

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  33 in total

1.  Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Authors:  Mónica Campillos; Miguel Angel García; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

2.  Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity.

Authors:  Mónica Campillos; José Ramón Lamas; Miguel Angel García; María Jesús Bullido; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

3.  Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.

Authors:  K R Bales; T Verina; D J Cummins; Y Du; R C Dodel; J Saura; C E Fishman; C A DeLong; P Piccardo; V Petegnief; B Ghetti; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 4.  The ApoE gene of Alzheimer's disease (AD).

Authors:  P K Krishnan Namboori; K V Vineeth; V Rohith; Ibnul Hassan; Lekshmi Sekhar; Akhila Sekhar; M Nidheesh
Journal:  Funct Integr Genomics       Date:  2011-07-19       Impact factor: 3.410

5.  APOE -491 T allele may reduce the risk of atherosclerotic lesions among middle-aged women.

Authors:  Virginia G Bañares; Ariel Bardach; Graciela Peterson; Marcelo J Tavella; Laura E Schreier
Journal:  Mol Cell Biochem       Date:  2011-11-22       Impact factor: 3.396

6.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

7.  Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism.

Authors:  Jari H Stengård; Andrew G Clark; Kenneth M Weiss; Sharon Kardia; Deborah A Nickerson; Veikko Salomaa; Christian Ehnholm; Eric Boerwinkle; Charles F Sing
Journal:  Am J Hum Genet       Date:  2002-08-05       Impact factor: 11.025

8.  The association of apolipoprotein E gene polymorphisms with cerebral palsy in Chinese infants.

Authors:  Yiran Xu; Honglian Wang; Yanyan Sun; Qing Shang; Mingjie Chen; Tongchuan Li; Dengna Zhu; Lin He; Changlian Zhu; Qinghe Xing
Journal:  Mol Genet Genomics       Date:  2014-02-13       Impact factor: 3.291

9.  The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia.

Authors:  Marianna Trebunová; Eva Slabá; Viera Habalová; Zuzana Gdovinová
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

10.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.

Authors:  Kristin K Nicodemus; Judith E Stenger; Donald E Schmechel; Kathleen A Welsh-Bohmer; Ann M Saunders; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-09-29       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.